180 related articles for article (PubMed ID: 19948385)
21. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
Rachev E; Nalbansky B; Kolarov G; Agrosì M
Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
[TBL] [Abstract][Full Text] [Related]
22. [Red clover isoflavones inhibit the proliferation and promote the apoptosis of benign prostatic hyperplasia stromal cells].
Chen MY; Yan SC; Yin CP; Ye L; Zhang MK; Yang J; Liu JH
Zhonghua Nan Ke Xue; 2010 Jan; 16(1):34-9. PubMed ID: 20180402
[TBL] [Abstract][Full Text] [Related]
23. Effects of one-year treatment with isoflavone extract from red clover on prostate, liver function, sexual function, and quality of life in men with elevated PSA levels and negative prostate biopsy findings.
Engelhardt PF; Riedl CR
Urology; 2008 Feb; 71(2):185-90; discussion 190. PubMed ID: 18308079
[TBL] [Abstract][Full Text] [Related]
24. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
[TBL] [Abstract][Full Text] [Related]
25. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.
Ishiwata N; Melby MK; Mizuno S; Watanabe S
Menopause; 2009; 16(1):141-8. PubMed ID: 19131846
[TBL] [Abstract][Full Text] [Related]
26. Effect of isoflavones on lipids and bone turnover markers in menopausal women.
Schult TM; Ensrud KE; Blackwell T; Ettinger B; Wallace R; Tice JA
Maturitas; 2004 Jul; 48(3):209-18. PubMed ID: 15207886
[TBL] [Abstract][Full Text] [Related]
27. Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats.
Pakalapati G; Li L; Gretz N; Koch E; Wink M
Phytomedicine; 2009 Sep; 16(9):845-55. PubMed ID: 19409770
[TBL] [Abstract][Full Text] [Related]
28. Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells.
Simoncini T; Garibaldi S; Fu XD; Pisaneschi S; Begliuomini S; Baldacci C; Lenzi E; Goglia L; Giretti MS; Genazzani AR
Menopause; 2008; 15(3):542-50. PubMed ID: 18467954
[TBL] [Abstract][Full Text] [Related]
29. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement.
Campagnoli C; Abbà C; Ambroggio S; Peris C; Perona M; Sanseverino P
Maturitas; 2005 Jun; 51(2):127-34. PubMed ID: 15917152
[TBL] [Abstract][Full Text] [Related]
30. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
31. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
32. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes.
Howes JB; Tran D; Brillante D; Howes LG
Diabetes Obes Metab; 2003 Sep; 5(5):325-32. PubMed ID: 12940870
[TBL] [Abstract][Full Text] [Related]
33. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety].
De Leo V; La Marca A; Lanzetta D; Palazzi S; Torricelli M; Facchini C; Morgante G
Minerva Ginecol; 2000 Jun; 52(6):263-7. PubMed ID: 11085051
[TBL] [Abstract][Full Text] [Related]
36. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
37. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression.
Sayyah M; Sayyah M; Kamalinejad M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):166-9. PubMed ID: 16309809
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial.
Shakeri F; Taavoni S; Goushegir A; Haghani H
Climacteric; 2015; 18(4):568-73. PubMed ID: 25581426
[TBL] [Abstract][Full Text] [Related]
40. Kava treatment in patients with anxiety.
Geier FP; Konstantinowicz T
Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
